LITTLE GREEN PHARMA LIMITED (LGP)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

LGP - LITTLE GREEN PHARMA LIMITED

Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: -1.04
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.14

15 Apr
2024

0.000

OPEN

$0.14

0.000

HIGH

$0.14

30,816

LOW

$0.14

OTHER COMPANIES IN THE SAME SECTOR
1AD . ACR . ACW . ADO . AFP . AGH . ARX . AVH . BIO . BOT . CSL . CUV . EOF . GSS . HXL . IDT . IMM . IMU . IVX . MAP . MDC . MSB . MVP . MYX . NEU . NXS . OCC . OPT . OSL . PAR . PBP . PER . PNV . PYC . RAC . RCE . SPL . TLX . TRP . VIT . ZNO .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 20182019202020222023
EPS Basic xxxxxxxxxxxx-3.4
DPS All xxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxx19.9 M
Book Value Per Share xxxxxxxxxxxx27.6
Net Operating Cash Flow xxxxxxxxxxxx-6.9 M
Net Profit Margin xxxxxxxxxxxx-43.09 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20182019202020222023
Return on Capital Employed xxxxxxxxxxxx-10.85 %
Return on Invested Capital xxxxxxxxxxxx-10.25 %
Return on Assets xxxxxxxxxxxx-8.80 %
Return on Equity xxxxxxxxxxxx-10.85 %
Return on Total Capital xxxxxxxxxxxx-15.58 %
Free Cash Flow ex dividends xxxxxxxxxxxx-8.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 20182019202020222023
Short-Term Debt xxxxxxxxxxxx7 M
Long Term Debt xxxxxxxxxxxx5 M
Total Debt xxxxxxxxxxxx12 M
Goodwill - Gross xxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxx12 M
Price To Book Value xxxxxxxxxxxx0.65

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 20182019202020222023
Capex xxxxxxxxxxxx4.9 M
Capex % of Sales xxxxxxxxxxxx24.82 %
Cost of Goods Sold xxxxxxxxxxxx12 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxx22 M
Research & Development xxxxxxxxxxxx7 M
Investments - Total xxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

LGP STOCK CHART